Search

The article discusses stroke risks, symptoms, and prevention, emphasizing the importance of prompt action in seeking treatment to reduce the impact on brain function and highlighting treatment options like mechanical thrombectomy.

The article reports on a license agreement signed by the Council of Scientific and Industrial Research's Central Drug Research Institute with Marc Laboratories, India to develop a drug for stroke and heart attack.

The article discusses the edge in stroke treatment offered by Plaza Medical Center facility in Fort Worth, Texas as of May 2016. Topics covered the center's large pool of physicians in its stroke team that can respond 24 hours a day, and the case of a patient who survived an ischemic stroke and has since maintained a healthy lifestyle. Also noted is the increasing number of 30-year-olds who are at risk for strokes.

The article presents information on the medical personnel who has completed their educational qualifications, highlighting their professional positions and their achievements. Topics include certifications received by Rodney Anderson for neurology and investigation of prevention of stroke, Becky G. Farley who provides Parkinson-specific training, and Sherry Chow who involved in the development of chemotherapy agents.

The article reports on doctors' hesitations to use tissue plasminogen activator (T.P.A.), a drug for people experiencing a stroke, which was found after an investigation prompted by a tip from a Canadian emergency medicine doctor, and mentions issues surrounding clinical trials.

The article focuses a 43-years old lady Holly Gambal who has worked to rebuild her cognitive and word skills after getting medication for stroke and got support from the New York Times Neediest Cases Fund.

The article discusses efforts by U.S. hospitals to hasten treatment for stroke victims. Technology such as mobile robots and video conferencing that make it possible for neurologists to diagnose patients remotely can reduce delays in the administration of vital treatments including the intravenous drug tPA (tissue plasminogen activator). Under an initiative called Target Stroke hospitals coordinate with emergency medical staff to diagnose patients before arriving at a hospital.

The article focuses on the love story of the couple Naveen Selvadurai and Diana Marie Hardeman and mentions the couple's marriage, treatment of Diana Marie Hardeman's stroke, and information on the couple's families.

The article focuses on inspiration to a 13 year old girl Lucy Friedland from challenges faced by her brother Adam Friedland to write a book "Take a Tall Walk with Me." Topics discussed include treatment of Adam for massive stroke in utero by horse riding therapy, introduction of the book at Mane Stream, Oldwick, New Jersey-based nonprofit center to serve children with mental and physical disabilities, hopes of Lucy for the book as part of Torah discussions.

The article reports that administration of magnesium in the ambulance aimed at treating stroke was found to have not delivered favorable outcomes according to the conclusion of the FAST-MAG clinical trial, which was participated by 1,700 patients who received magnesium within 2 hours of stroke onset.

The article discusses the life-saving potential and risks associated with the use of decompressive craniectomy (hemicraniectomy) as a surgical method for treating brain trauma as of July 15, 2013. Topics addressed include patients who suffer from significant cognitive and motor impairments following the surgery, the use of hemicraniectomy in treating strokes, and research studies on the effectiveness of the procedure.

A personal narrative is presented in which the author explores his experience of having a stroke and recovering.

The article discusses three studies, including the IMS III study and the MR RESCUE trial presented at the International Stroke Conference 2013 which found that the more invasive and expensive endovascular therapy does not achieve superior outcomes to standard treatment for stroke.

The article discusses the potential of combined clopidogrel and aspirin therapies to reduce the risk for a second stroke based on a study by Yongjun Wang and colleagues, presented at the International Stroke Conference held in Honolulu, Hawaii in 2013.

The article offers information on former Israeli President Shimon Peres, who is suffering from stroke and undergoes into medical treatment at Sheba Medical Center in Tel HaShomer in Ramat Gan, Israel.

The article discusses the agreement between Methodist Hospital, San Antonio, TX and Connally Memorial Medical Center, Floresville, TX for emergency service to stroke victims.

The article offers information on the Emergency Medical Services (EMS) Summit hosted by the Connally Memorial Medical Center in Floresville, Texas, on February 24, 2016, that featured hospital's chief executive officer (CEO) Brian Burnside who discussed the hospital's cardiac and stroke treatment.

The article reports on the article published in the "New England Journa of Medicine" which offers instructions to doctors on the best ways for responding to cardiac arrest, acute coronary symptoms, and strokes on board.

The article discusses research at RMIT University's Cerebrovascular and Stroke Laboratory on treating brain damage resulting from strokes. RMIT researchers Alyson Miller and Sarah Spencer are noted in relation to the project "Investigating a Novel Agent to Limit Brain Injury and Post-Stroke Complications," which is studying the hormone ghrelin in relation to stroke treatment.

The article discusses a study which showed that the use of a stent-retriever to extract blood clots from brain arteries can improve the ability of patients to recover from a stroke, referencing a research published in the "New England Journal of Medicine."

The article reports on a study that discovers a treatment that improves the prognosis for people having the most severe and disabling strokes.

The article discusses research completed by researchers at the Monash University School of Biological Sciences in Melbourne, Victoria that found men and women must be treated differently for strokes, and examines the role of oestrogen receptors in alleviating the effects of strokes.

The article presents information on research regarding technology and therapy for stroke treatment. The author looks at the creation of a micromotor by professors James Friend and Leslie Yeo and the research project "Investigating a Novel Agent to Limit Brain Injury and Post-Stroke Complications" being conducted by doctors Alyson Miller and Sarah Spencer.

The article provides information on a study which found that despite the fact that most Americans have access to stroke care, few get recommended treatment.

MILLIONS more Britons could be given statins to cut their risk of heart attacks and strokes after US guidelines recommended a third of adults should take them. [ABSTRACT FROM PUBLISHER]

The article provides information on University of California (UC) Irvine Medical Center of UC Irvine Health that provides stroke care in Orange County, California, which is described by The Joint Commission as one of the medical centers delivering state-of-the-art care to stroke patients.

The article offers information on Mission Hospital which is the only hospital in south Orange County, California that was certified as a Primary Stroke Center by The Joint Commission as well as a designated Stroke-Neurology Receiving Center.

The article discusses a report issued by the American Heart Association and the American Stroke Association which projected that the cost of stroke will double by 2030.

The article provides information on several medical innovations covering topics such as stroke treatment, the use of gastric bypass surgery to treat type two diabetes, and mammograms.

The article discusses research on the effectiveness of stenting as treatment for stroke, referencing to a study that was conducted by neurologist Martin Roubec and colleagues, and published in the journal "Radiology" in 2012.

The article reports on the trip of Iraq President Jalal Talabani to Germany on December 20, 2012 to seek medical treatment for stroke.

The article reports on the rise in the number of hospital patients in Germany due to its advance healthcare systems. It mentions that President Jalal Talabani of Iraq for treatment of his stroke. It notes that the number of hospital patients from the United Arab Emirates increased to 1,754 from 339 between 2000 and 2010. It also reveals that rich Arabs visit Germany in the summer to escape from the heat in their country according to Salah Atamna, owner of the business Europe Health.

The article reports that Iraq President Jalal Talabani has been brought to Germany for medical treatment for stroke. Barazan Sheikh Othman, the head of the president's media office, says that Talabani's health is better and that he can travel to Germany to continue treatment. However, other officials privately confirm that the president's condition is serious and he was in a coma.

The article reports on a study conducted by the University of Pennsylvania researchers on the efficacy of aspirin in treating strokes and heart attacks. The study tested 400 people for evidence that aspirin did not work in them, which is called aspirin resistance. Moreover, cardiologists advised patients to look for uncoated aspirin due to other studies, which suggest that the uncoated type may be more effective.

The article focuses on the study published in the December 4, 2012 issue "Circulation" which discusses the effectiveness of coated aspirin in preventing strokes and heart attacks. It states that a study found that the protective coating might obscure the therapeutic effect of aspirin. It mentions that Bayer AG, the world's largest producer of branded aspirin, partly financed the study.

The article discusses research on the risk of disability following ischemic attack or minor stroke treatment, referencing a study published in "Stroke."

An article on Monday about Eliquis, a new stroke-preventive drug from Pfizer and Bristol-Myers Squibb, misspelled the brand name of the drug most commonly used now for that purpose. It is Coumadin, not Coumidin. [ABSTRACT FROM AUTHOR]